# Vraylar

NDC: 61874-250
Generic name: cariprazine
Labeler / Manufacturer: Allergan, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, GELATIN COATED
Routes: ORAL
Marketing started: 20251218

FDA application: NDA204370

## Active ingredients

- CARIPRAZINE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61874-250"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61874-250
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b5f7c65-aa2d-452a-b3db-bc85c06ff12f